Subscribe for real-time financial insights on Trade Target’s WhatsApp Channels
Medicamen Organics Limited, founded in 1995 develops, manufactures and distributes various pharmaceutical dosages including tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders. They serve both government bodies and private companies as a contract manufacturer.
The company offers a wide range of 84 products including antibiotics, antifungal medications, antimalarials, antidiabetics, proton pump inhibitors, antihistamines, blood pressure medications, lipid lowering drugs, antiparasitics, multivitamins, minerals and pain relievers.
Medicamen Organics markets its products across India and in several international regions including Africa, CIS and South East Asia through third party distributors. Some of the countries they serve are Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan and Kenya.
Medicamen Organics IPO Overview
Medicamen Organics aims to raise a total of ₹10.54 crores through its IPO, which consists entirely of a fresh issue of shares. The price range for the IPO is set between ₹32 and ₹34 per share.
Medicamen Organics IPO will be open for subscription from 21 to 25 June. Share allotment is expected by 26 June 2024 and the shares are set to be listed on NSE SME segment by 28 June 2024.
Mr. Bal Kishan Gupta currently holds 81.21% ownership of the company. However, his holding will decrease after the listing. Kfin Technologies is the registrar for the Medicamen Organics IPO.
Medicamen Organics IPO GMP
As of June 17, Medicamen Organics IPO has a Grey Market Premium of ₹50. With the upper price band set at ₹34, the estimated listing price is ₹84 (Upper price band + today’s GMP). Indicating an expected gain of 147.06% per share.
Stay tuned with Trade Target for daily updates on Medicamen Organics IPO GMP and the expected listing price.
- Date: 26– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 25– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 24– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 23– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 22– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 21– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 20– June – 2024
- Medicamen Organics GMP: ₹50 (147.06%)
- Date: 19– June – 2024
- Medicamen Organics GMP: ₹60 (176.47%)
- Date: 18– June – 2024
- Medicamen Organics GMP: ₹60 (176.47%)
- Date: 17– June – 2024
- Medicamen Organics GMP: ₹60 (176.47%)
How can one apply for Medicamen Organics IPO?
For retail investors minimum investment starts with 1 lot including 4,000 shares at a cost of ₹136,000 and this is the maximum limit for retail investors to apply in Medicamen Organics IPO
For HNIs minimum investment is set at 2 lots including 8,000 shares and costs ₹272,000.
| Application | Lots | Shares | Amount |
|---|---|---|---|
|
Retail (Min) |
1 |
4000 |
₹136,000
|
|
Retail (Max) |
1 |
4000 |
₹136,000
|
|
S-HNI (Min) |
2 |
8000 |
₹272,000
|
Medicamen Organics IPO Financial
As of March 31, 2023, Medicamen Organics has reported a PAT of ₹95.78 lakhs. This shows an increase compared to the PAT of ₹9.23 lakhs reported on March 31, 2022 and ₹29.81 lakhs on March 31, 2021.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
|
Assets in (₹ Lakhs) |
3,211.98
|
2,707.21
|
2,634.37
|
|
Revenue (₹ Lakhs) |
2,296.24
|
2,118.67
|
2,505.96
|
|
PAT (₹ Lakhs)
|
95.78
|
9.23
|
29.81
|
|
Total Borrowing (₹ Lakhs)
|
1,179.50
|
1,024.57
|
958.97
|
Medicamen Organics Vs Peers
Medicamen Organics has very low EPS and decent P/E in comparison to its peers. Higher EPS is always considered good.
| Company | EPS Diluted | P/E(x) |
|---|---|---|
|
Medicamen Organics Limited
|
1.6
|
30.53
|
|
Brooks Laboratories Ltd.
|
-12.57
|
10.6
|
|
Cian Healthcare Ltd
|
0.43
|
53.84
|
|
Zenotech Laboratories Ltd.
|
1.9
|
38.76
|
Medicamen Organics IPO Quota allocation
- QIB Investors: 50% of the net issue
- Retail Investors: 35% of the net issue
- NII (HNI) Investors: 15% of the net issue
Expected Listing Date for Medicamen Organics IPO
- Subscription Period: 21 June to 25 June
- Basis of Allotment Finalization: 26 June 2024
- Initiation of Refunds: 27 June 2024
- Demat Credits: 27 June 2024
- Listing Date: 28 June 2024
- Listing on: NSE SME
